Birchview Capital, LP 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
Birchview Capital, LP disclosed 68 US equity positions worth $122.9m in its Q4 2024 13F filing. The largest position was BMY at 31.5% of the reported book, followed by BDSX and ACAD. Against the Q3 2024 filing, it opened 6 new positions, added to 10 and reduced 6 among the top 50 holdings.
What did Birchview Capital, LP own in Q4 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2024 |
|---|---|---|---|---|---|---|---|
| 1 | BMY BRISTOL-MYERS SQUIBB CO | Healthcare | 31.5% | $38.8m | 685,182 | -0% | held |
| 2 | BDSX BIODESIX INC | 7.1% | $8.8m | 5,736,113 | 1% | added | |
| 3 | ACAD ACADIA PHARMACEUTICALS INC | Healthcare | 5.1% | $6.2m | 338,400 | -15% | reduced |
| 4 | ELUT ELUTIA INC | 3.7% | $4.6m | 1,225,489 | -7% | reduced | |
| 5 | PROTHENA CORP PLC | 3.4% | $4.2m | 304,574 | 45% | added | |
| 6 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 3.4% | $4.1m | 30,240 | 0% | held |
| 7 | CORT CORCEPT THERAPEUTICS INC | Healthcare | 3.0% | $3.7m | 74,000 | 0% | held |
| 8 | UTHR UNITED THERAPEUTICS CORP | Healthcare | 2.9% | $3.5m | 10,000 | 0% | held |
| 9 | AXGN AXOGEN INC | Healthcare | 2.6% | $3.2m | 197,000 | 0% | held |
| 10 | DCGO DOCGO INC | 2.6% | $3.2m | 764,062 | 48% | added | |
| 11 | QDELUSD QUIDELORTHO CORP | 2.5% | $3.0m | 67,619 | 0% | held | |
| 12 | PHR PHREESIA INC | Healthcare | 2.3% | $2.9m | 114,700 | 0% | held |
| 13 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 2.1% | $2.6m | 148,000 | 0% | held |
| 14 | MASI* MASIMO CORP | 2.1% | $2.5m | 15,280 | 0% | held | |
| 15 | HROW HARROW HEALTH INC | 2.0% | $2.4m | 72,910 | 0% | held | |
| 16 | STOK STOKE THERAPEUTICS INC | Healthcare | 1.9% | $2.3m | 210,000 | 0% | held |
| 17 | OVV OVINTIV INC | Energy | 1.7% | $2.1m | 52,200 | 0% | held |
| 18 | CSTL CASTLE BIOSCIENCES INC | Healthcare | 1.7% | $2.1m | 78,000 | 34% | added |
| 19 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 1.5% | $1.9m | 48,000 | 0% | held |
| 20 | EQT EQT CORPORATION | Energy | 1.3% | $1.6m | 34,619 | 0% | held |
| 21 | FHTX FOGHORN THERAPEUTICS INC | Healthcare | 1.2% | $1.5m | 310,930 | -3% | reduced |
| 22 | ALKS ALKERMES PLC | Healthcare | 1.2% | $1.4m | 50,000 | 0% | held |
| 23 | TMCI TREACE MEDICAL CONCEPTS INC | Healthcare | 1.0% | $1.2m | 161,350 | 136% | added |
| 24 | NVCR NOVOCURE LTD | Healthcare | 0.8% | $923.8k | 31,000 | 55% | added |
| 25 | TXG 10X GENOMICS INC | Healthcare | 0.6% | $718.0k | 50,000 | 67% | added |
| 26 | RARE ULTRAGENYX PHARMACEUTICAL INC | Healthcare | 0.5% | $673.1k | 16,000 | – | new |
| 27 | XNCR XENCOR INC | Healthcare | 0.5% | $597.5k | 26,000 | 111% | added |
| 28 | KINIKSA PHARMACEUTICALS LTD | 0.5% | $593.4k | 30,000 | 0% | held | |
| 29 | 4XC1 KALVISTA PHARMACEUTICALS INC | 0.5% | $567.5k | 67,000 | -18% | reduced | |
| 30 | ATEC ALPHATEC HOLDINGS INC | Healthcare | 0.4% | $532.4k | 58,000 | -71% | reduced |
| 31 | CADL CANDEL THERAPEUTICS INC | 0.4% | $520.8k | 60,000 | – | new | |
| 32 | WVE WAVE LIFE SCIENCES LTD | Healthcare | 0.4% | $494.8k | 40,000 | 0% | held |
| 33 | INBX INHIBRX BIOSCIENCES INC | 0.4% | $494.5k | 32,110 | 0% | held | |
| 34 | HALO HALOZYME THERAPEUTICS INC | Healthcare | 0.4% | $478.1k | 10,000 | 0% | held |
| 35 | CYTK CYTOKINETICS INC | Healthcare | 0.4% | $470.4k | 10,000 | 0% | held |
| 36 | APLSUSD APELLIS PHARMACEUTICALS INC | 0.4% | $446.7k | 14,000 | 0% | held | |
| 37 | SRPT SAREPTA THERAPEUTICS INC | Healthcare | 0.3% | $425.6k | 3,500 | 40% | added |
| 38 | OMGBP OUTSET MEDICAL INC | 0.3% | $409.3k | 368,766 | 3588% | added | |
| 39 | XENE XENON PHARMACEUTICALS INC | Healthcare | 0.3% | $392.0k | 10,000 | 0% | held |
| 40 | ACCELERATE DIAGNOSTICS INC | 0.3% | $390.3k | 325,239 | 0% | held | |
| 41 | TELA TELA BIO INC | 0.3% | $377.5k | 125,000 | – | new | |
| 42 | SWTXUSD SPRINGWORKS THERAPEUTICS INC | 0.3% | $361.3k | 10,000 | 0% | held | |
| 43 | QURE UNIQURE NV | 0.3% | $353.2k | 20,000 | 0% | held | |
| 44 | LUNG PULMONX CORP | Healthcare | 0.3% | $346.3k | 51,000 | – | new |
| 45 | SRRK SCHOLAR ROCK HOLDING CORP | Healthcare | 0.3% | $345.8k | 8,000 | – | new |
| 46 | AXSM AXSOME THERAPEUTICS INC | Healthcare | 0.3% | $338.4k | 4,000 | 0% | held |
| 47 | BCRX BIOCRYST PHARMACEUTICALS INC | Healthcare | 0.2% | $300.8k | 40,000 | 0% | held |
| 48 | ATRA ATARA BIOTHERAPEUTICS INC | 0.2% | $292.8k | 22,000 | – | new | |
| 49 | ARVN ARVINAS INC | Healthcare | 0.2% | $287.6k | 15,000 | 0% | held |
| 50 | KPTI KARYOPHARM THERAPEUTICS INC | Healthcare | 0.2% | $283.9k | 419,832 | -11% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.